A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.

Summary

This study is a single-arm, multicenter, open-label clinical study evaluating the efficacy and safety of axicabtagene ciloleucel injection manufactured by an automated cell preparation process in adult subjects with relapsed or refractory large B-cell lymphoma (r/r LBCL) as second-line therapy.

Timeline

Start

2026-06-12

Primary completion

2026-11-30

Completion

2026-12-31

Drugs

Indications